Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Scopus BioPharma Inc. (SCPS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-Q10-K10-Q10-Q10-Q
Revenues  0.00.00.00.00.00.00.00.0
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.00.00.00.00.00.00.0
Selling, general and administrative   [+]0.91.12.74.36.42.71.71.8
Research and development  2.01.60.60.40.10.113.61.3
Other operating expenses  -2.9 -3.3     
EBITDA   [+]0.0-2.70.0-4.7-6.5-2.8-15.3-3.1
Depreciation and amortization  0.00.00.00.00.00.00.00.0
EBIT   [+]0.0-2.70.0-4.7-6.5-2.8-15.3-3.1
Interest expense       0.10.30.3
Other income (expense), net   [+]-2.9 -3.3  1.50.0 
Pre-tax income  -2.9-2.7-3.3-4.7-6.5-1.4-15.6-3.4
Income taxes  -0.3-0.20.00.00.00.00.00.0
            Tax rate  10.7%8.6%0.0%0.0%0.0%0.0%0.0%0.0%
Minority interest  -0.3-0.2      
Net income  -2.6-2.4-3.3-4.7-6.5-1.4-15.6-3.4
   
Basic EPS   [+]($0.07)($0.08)($0.16)($0.22)($0.38)($0.08)($0.97)($0.22)
Diluted EPS   [+]($0.07)($0.08)($0.16)($0.22)($0.38)($0.08)($0.97)($0.22)
   
Shares outstanding (basic)   [+]39.730.421.121.117.317.116.215.3
Shares outstanding (diluted)   [+]39.730.421.121.117.317.116.215.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy